High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 7, 2003, Pages 663-667

  Bakos, Noémi ^a   Fekete, B ^b   Prohaszka Z ^b   Fust G ^b   Kalabay, L ^b  

^a Hetenyi Geza County Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Anti lpp20 antibodies; Chronic urticaria; Helicobacter pylori

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOPROTEIN; LIPOPROTEIN 220; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; MALE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CHRONIC DISEASE; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOPROTEINS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PREVALENCE; URTICARIA;

EID: 0037561053     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00200.x     Document Type: Article

References (35)

1. GREAVES MW. Pathophysiology of chronic urticaria. Int Arch Allergy Immunol 2002;127:3-9.
2. HIDE M, FRANCIS DM, GRATTAN CEH, HAKIMI J, KOCHAN JP, GREAVES MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
3. GREAVES M. Chronic urticaria. J Allergy Clin Immunol 2000;105:664-672.
4. SABROE RA, GRATTAN CEH, FRANCIS DM, BARR RM, BLACK AK, GRAEVES MW. The autologous serum skin test: a screening test for autoantibodies in chronic urticaria. Br J Dermatol 1999;140:446-452.
5. DI CAMPLI C, GASBARRINI A, NUCERA E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998;43:1226-1229.
6. WUSTLICH S, BRECLER R, LUGER TA, POHLE T, DOMSCHKE W, FOERSTER E. Helicobacter as a possible bacterial focus of chronic urticaria. Dermatology 1999;198:130-132.
7. TEBBE B, GEILEN CG, SCHULZKE JD, BOJARSKI C, RADEHAUSEN M, ORFANOS CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996;34:685-686.
8. SCHNYDER B, HELBLING A, PICHLER WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999;119:60-63.
9. WEDI B, WAGNER S, WERFEL T, MANNS MP, KAPP A. Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol 1998;116:288-294.
10. GREAVES MW. Chronic idiopathic urticaria and Helicobacter pylori - not directly causative, but could there be a link? ACI Int 2001;13:23-26.
11. HIZAL M, TUZUN B, WOLF R, TUZUN Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000;39:443-445.
12. COVER TL, BLASER MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-10575.
13. COVER TL, HANSON PI, HEUSER JE. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J Cell Biol 1997;138:759-769.
14. KOSTRYNSKA M, O'TOOLE PW, TAYLOR DE, TRUST TJ. Molecular characterization of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori. J Bacteriol 1994;176:5938-5948.
15. BAKOS N, HILLANDER M, VICZIÁN Á, FEKETE B, FÙST G. Investigation of chronic urticaria associated with Helicobacter pylori. Immunol Lett 2000;73:276.
16. NIIMI N, FRANCIS DM, KERMANI F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106:1001-1006.
17. FIEBIGER E, MAURER D, HOLUB H, et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995;96:2606-2612.
18. FIEBIGER E, HAMMERSCHMID F, STINGL G, MAURER D. Anti-FceRI autoantibodies in autoimmune-mediated disorder: identification of a structure-function relationship. J Clin Invest 1998;101:243-251.
19. FERRER M, NAKAZAWA K, KAPLAN AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999;104:169-172.
20. ROITT IM. Essential immunology, 6th edn. Oxford: Blackwell Science, 1988.
21. NEGRINI R, SAVIO A, APPELMELK BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997;2:13-16.
22. FIGURA N, GIORDANO N, BURRONI D, et al. Sjögren's syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994;6:321-322.
23. KALABAY L, FEKETE B, CZIRJÁK L, et al. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial Hsp65 but not to human Hsp60. Helicobacter 2002;7:250-257.
24. REINAUER S, MEGAHED M, GOERZ G, et al. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995;33:876-879.
25. FIGURA N, DI CAIRANO G, LORE F, et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999;50:817-826.
26. LEZNOFF A, SUSSMAN GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989;84:66-71.
27. TURKTAS I, GOKCORA N, DEMIRSOY S, CAKIR N, ONAL E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997;36:187-190.
28. GAIG P, GARCIA-ORTEGA P, ENRIQUE E, RICHART C. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Invest Allerg Clin Immunol 2000;10:342-345.
29. KOSTRZYNSKA M, O'TOOLE PW, TAYLOR DE, TRUST TJ. Molecular characterisation of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori. J Bacteriol 1994;176:5938-5948.
30. KEENAN JI, ALLARDYCE RA, BAGSHAW PF. A role for the bacterial outer membrane in the pathogenesis of H. pylori infection. FEMS Microbiol Lett 2000;182:259-264.
31. MAI UEH, PEREZ-PEREZ GI, WAHL LM, WAHL SM, BLASER MJ, SMITH PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by a lipopolysaccharide-independent mechanism. J Clin Invest 1991;87:894-900.
32. CAO P, MCCLAIN MS, FORSYTH MH, COVER TL. Extracellular release of antigenic proteins by Helicobacter pylori. Infect Immun 1998;66:2984-2986.
33. HAUPL T, LANDGRAF S, NETUSIL P, et al. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunol Med Microbiol 1997;19:15-23.
34. VAARALA O, ALFTHAN G, JAUHIAINEN M, LEIRISALO-REPO M, AHO K, PALOUSO T. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-925.
35. KEENAN J, OLIARO J, DOIGAN N, et al. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun 2000;68:3337-3343.